GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Construction In Progress

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Construction In Progress : ¥645 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Construction In Progress?

China Resources Double-Crane Pharmaceutical Co's quarterly construction in progress declined from Sep. 2023 (¥613 Mil) to Dec. 2023 (¥568 Mil) but then increased from Dec. 2023 (¥568 Mil) to Mar. 2024 (¥645 Mil).

China Resources Double-Crane Pharmaceutical Co's annual construction in progress increased from Dec. 2021 (¥273 Mil) to Dec. 2022 (¥440 Mil) and increased from Dec. 2022 (¥440 Mil) to Dec. 2023 (¥568 Mil).

China Resources Double-Crane Pharmaceutical Co Construction In Progress Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Construction In Progress Chart

China Resources Double-Crane Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 244.22 281.04 272.81 439.72 568.24

China Resources Double-Crane Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 475.08 536.63 612.96 568.24 645.12

China Resources Double-Crane Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Construction In Progress
Comparable Companies
SHSE:600380 SHSE:600329 SZSE:300601 SHSE:600535 SHSE:603707 SHSE:600521 SZSE:300142 SHSE:600867 SHSE:600129 SZSE:002262 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
Website
http://www.dcpc.com
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines